Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Double-blind Placebo-controlled Randomized Parallel-group Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia.

NCT04552041 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT04552041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04552041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Double-blind Placebo-controlled Randomized Parallel-group Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia.
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Completed
Start date
December 3, 2020
Completion date
September 22, 2022
Enrollment
406 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

vascular dementia